TRML logo

Tourmaline Bio, Inc. (TRML) EBIT

annual EBIT:

-$89.73M-$44.32M(-97.61%)
December 31, 2024

Summary

  • As of today (September 15, 2025), TRML annual earnings before interest & taxes is -$89.73 million, with the most recent change of -$44.32 million (-97.61%) on December 31, 2024.
  • During the last 3 years, TRML annual EBIT has fallen by -$42.23 million (-88.88%).
  • TRML annual EBIT is now -388.26% below its all-time high of -$18.38 million, reached on December 1, 2019.

Performance

TRML EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLincome statement metrics

quarterly EBIT:

-$25.97M+$257.00K(+0.98%)
June 30, 2025

Summary

  • As of today (September 15, 2025), TRML quarterly earnings before interest & taxes is -$25.97 million, with the most recent change of +$257.00 thousand (+0.98%) on June 30, 2025.
  • Over the past year, TRML quarterly EBIT has dropped by -$4.00 million (-18.22%).
  • TRML quarterly EBIT is now -448.32% below its all-time high of -$4.74 million, reached on June 1, 2020.

Performance

TRML quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLincome statement metrics

TTM EBIT:

-$102.45M-$4.00M(-4.07%)
June 30, 2025

Summary

  • As of today (September 15, 2025), TRML TTM earnings before interest & taxes is -$102.45 million, with the most recent change of -$4.00 million (-4.07%) on June 30, 2025.
  • Over the past year, TRML TTM EBIT has dropped by -$41.43 million (-67.89%).
  • TRML TTM EBIT is now -1959.69% below its all-time high of -$4.97 million, reached on March 1, 2020.

Performance

TRML TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

TRML EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-97.6%-18.2%-67.9%
3 y3 years-88.9%-41.0%-59.4%
5 y5 years-388.3%-448.3%-546.4%

TRML EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-355.5%at low-427.9%+1.0%-189.1%at low
5 y5-year-388.3%at low-427.9%+1.0%-546.4%at low
alltimeall time-388.3%at low-448.3%+1.0%-1959.7%at low

TRML EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$25.97M(-1.0%)
-$102.45M(+4.1%)
Mar 2025
-
-$26.23M(+1.6%)
-$98.45M(+9.7%)
Dec 2024
-$89.73M(+97.6%)
-$25.81M(+5.6%)
-$89.73M(+13.8%)
Sep 2024
-
-$24.44M(+11.2%)
-$78.82M(+29.2%)
Jun 2024
-
-$21.97M(+25.4%)
-$61.02M(+10.1%)
Mar 2024
-
-$17.52M(+17.6%)
-$55.42M(+22.1%)
Dec 2023
-$45.41M(+130.5%)
-$14.89M(+124.1%)
-$45.41M(+28.1%)
Sep 2023
-
-$6.64M(-59.4%)
-$35.44M(-26.8%)
Jun 2023
-
-$16.37M(+118.3%)
-$48.38M(-4.0%)
Mar 2023
-
-$7.50M(+52.5%)
-$50.42M(-17.8%)
Dec 2022
-$19.70M
-
-
Dec 2022
-
-$4.92M(-74.9%)
-$61.34M(-13.4%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$19.59M(+6.4%)
-$70.81M(+10.2%)
Jun 2022
-
-$18.41M(+0.0%)
-$64.27M(+12.9%)
Mar 2022
-
-$18.41M(+28.0%)
-$56.92M(+19.8%)
Dec 2021
-$47.51M(+109.4%)
-$14.39M(+10.2%)
-$47.51M(+18.9%)
Sep 2021
-
-$13.06M(+18.1%)
-$39.95M(+20.9%)
Jun 2021
-
-$11.06M(+22.8%)
-$33.03M(+23.7%)
Mar 2021
-
-$9.01M(+31.7%)
-$26.71M(+17.8%)
Dec 2020
-$22.68M(+23.4%)
-$6.83M(+11.4%)
-$22.68M(+43.1%)
Sep 2020
-
-$6.14M(+29.6%)
-$15.85M(+63.2%)
Jun 2020
-
-$4.74M(-4.8%)
-$9.71M(+95.2%)
Mar 2020
-
-$4.97M
-$4.97M
Dec 2019
-$18.38M
-
-

FAQ

  • What is Tourmaline Bio, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. annual EBIT year-on-year change?
  • What is Tourmaline Bio, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. quarterly EBIT year-on-year change?
  • What is Tourmaline Bio, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. TTM EBIT year-on-year change?

What is Tourmaline Bio, Inc. annual earnings before interest & taxes?

The current annual EBIT of TRML is -$89.73M

What is the all time high annual EBIT for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high annual earnings before interest & taxes is -$18.38M

What is Tourmaline Bio, Inc. annual EBIT year-on-year change?

Over the past year, TRML annual earnings before interest & taxes has changed by -$44.32M (-97.61%)

What is Tourmaline Bio, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of TRML is -$25.97M

What is the all time high quarterly EBIT for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high quarterly earnings before interest & taxes is -$4.74M

What is Tourmaline Bio, Inc. quarterly EBIT year-on-year change?

Over the past year, TRML quarterly earnings before interest & taxes has changed by -$4.00M (-18.22%)

What is Tourmaline Bio, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of TRML is -$102.45M

What is the all time high TTM EBIT for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high TTM earnings before interest & taxes is -$4.97M

What is Tourmaline Bio, Inc. TTM EBIT year-on-year change?

Over the past year, TRML TTM earnings before interest & taxes has changed by -$41.43M (-67.89%)
On this page